Clinical Trial Detail

NCT ID NCT02685397
Title Management of Castration-Resistant Prostate Cancer With Oligometastases
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sir Mortimer B. Davis - Jewish General Hospital
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Triptorelin

Goserelin

Leuprolide

Age Groups: adult

No variant requirements are available.